GENERATION BIO CO

GBIO08 Feb 2025
Healthcare
$0.82
-0.06 (-5.73%)
Lowest Today
$0.75
Highest Today
$0.82
Today’s Open
$0.82
Prev. Close
$0.81
52 Week High
$4.65
52 Week Low
$0.72
To Invest in GENERATION BIO CO

GENERATION BIO CO

Healthcare
GBIO08 Feb 2025
-0.06 (-5.73%)
1M
3M
6M
1Y
5Y
Low
$0.75
Day’s Range
High
$0.82
0.75
52 Week Low
$0.72
52-Week Range
52 Week High
$4.65
0.72
1 Day
-
1 Week
-0.11%
1 month return
-16.62%
3 month return
-66.41%
6 month return
-67.83%
1 Year return
-60.46%
3 Years return
-86.56%
5 Years return
-96.79%
10 Years return
-
Institutional Holdings
T. Rowe Price New Horizons
7.99
US Small-Cap Growth II Equity Comp
7.99
Fidelity Growth Compy Commingled Pl S
2.99
Fidelity Growth Company Fund
2.66
T. Rowe Price Health Sciences
2.41
Vanguard Total Stock Mkt Idx Inv
2.33
iShares Russell 2000 ETF
1.98

Market Status

Fundamentals
Market Cap
53.81 mln
PB Ratio
0.53
PE Ratio
0
Enterprise Value
-35.41 mln
Total Assets
374.76 mln
Volume

Company Financials

Fund house & investment objective

Company Information
Generation Bio Co. develops non-viral genetic medicines for the treatment of rare and prevalent diseases. The company develops cell-targeted lipid nanoparticle (ctLNP) platform, a modular delivery system for nucleic acids to avoid off-target clearance by the liver and spleen that enables ctLNPs to persist in systemic circulation, which allows for highly selective and potent ligand-driven targeting to specific tissues and cell types; and novel immune-quiet DNA (iqDNA) to enable long-lasting high levels of gene expression from non-integrating episomes and avoids innate immune sensors that have long prevented DNA from use in non-viral systems. It uses its platform for developing a portfolio of programs for treating cancer, autoimmune, hematologic disorders, prioritizing sickle cell, beta-thalassemia, and hemophilia A diseases, as well as for other tissues and cell types, including retina, skeletal muscle, and central nervous system. The company was formerly known as Torus Therapeutics, Inc. and changed its name to Generation Bio Co. in November 2017. Generation Bio Co. was incorporated in 2016 and is headquartered in Cambridge, Massachusetts.
Organisation
GENERATION BIO CO
Employees
174
Industry
Biotechnology
CEO
Dr. Cameron Geoffrey McDonough M.D.
Trading and brokerage services provided by
Technology Services provided by Motilal Oswal Financial Services:

Take your next step

Click here to see your activities